Please find here an overview of guidance documents currently under development, either proposed or endorsed by ESCMID or its study groups.

The status of each project is defined based on the steps of the GIN-McMaster Guideline Development Checklist.

For more information please contact us at guidancedocuments[at]escmid.org.

  • ESCMID COVID-19 Guidelines: Outpatient treatment update (ESCMID)

Chair: Michele Bartoletti

 

Approval date: March 2021

Status (date): Reporting and peer review (April 2022)

 

  • the Update of the 2014 ESCMID guidelines for the management of the infection prevention & control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients (ESCMID)

Chair: Evelina Tacconelli

Approval date: December 2020

Status (date): Data extraction (April 2022)

 

  • Diagnosis and treatment of brain abscess (ESCMID)

Chair: Jacob Bodilsen

Approval date: December 2020

Status (date): Data extraction (April 2022)

 

  • Antibiotic surgical prophylaxis regimens among patients colonised by MDR-GNB and MDR-GPB (ESCMID)

Chair: Nico T. Mutters

Approval date: December 2019

Status (date): Summarizing Evidence and Considering Additional Information (April 2022)

 

  • Antimicrobial stewardship in the emergency department (ESCMID)

Chair: Jeroen Schouten

Approval date: December 2019

Status (date): Data Extraction (April 2022)

 

  • Influenza management and treatment (ESCMID)

Chair: Barbara Rath

Approval date: December 2019

Status (date): (PICO) Question Generation (February 2021)

 

  • Management of uncomplicated urinary tract infections (IDSA/ESCMID)

ESCMID representative: Angela Huttner

Approval date: April 2019

Status (date): Deciding what evidence to include and searching for evidence (May 2020)

 

  • Microbiological diagnosis of bloodstream infections (ESCMID/ESA)

Chair: Brigitte Lamy

Approval date: November 2018

Status (date): Literature search (April 2022)

 

  • Diagnosis and management of infective encephalitis (ESCMID/EAN)

ESCMID representative: Thomas Whitfield

Approval date: April 2018

Status (date): Deciding what evidence to include and searching for evidence (September 2021)

 

  • Rituals and behaviors in the operating room (ESCMID/HIS)

ESCMID representative: Gemma Marsden

Approval date: March 2018

Status (date): Judging quality, strength or certainty of a body of evidence (February 2021)

 

  • Management of severe community-acquired pneumonia (ERS/ALAT/ESCIM/ESCMID endorsement)

ESCMID representative: Matteo Bassetti

Approval date: October 2017

Status (date): PCP concluded (February 2022)

 

  • Management of Staphylococcus aureus bacteremia (IDSA/ESCMID)

ESCMID representative: Winfried Kern & François Vandenesch.

Approval date: January 2017.

Status (date): Deciding what evidence to include and searching for evidence (September 2021)